predominantly classic do not respond well to OPT but FDA probably forced opthea to include this subtype in ph3 study (despite being only ~12% of total wet amd population - lucky for us it’s only 10% of total patient pool for ph3
The big money is in occult and minimally classic (75%+ of patients) and opt performs very well with RAP absent . PCV is even better. 80% of Coast patient pool is occult and PCV which are by far the best responders to OPT. In summary, I think 5 letters for COAST probably the minimum we will see.![]()
- Forums
- ASX - By Stock
- OPT
- Ann: Security Class Reinstatement to Quotation- OPTOB
OPT
opthea limited
Add to My Watchlist
0.00%
!
60.0¢

Ann: Security Class Reinstatement to Quotation- OPTOB, page-574
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
60.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $738.7M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
OPT (ASX) Chart |
Day chart unavailable
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online